Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price traded up 2.6% on Friday . The stock traded as high as GBX 78 ($0.98) and last traded at GBX 78 ($0.98). 42 shares were traded during trading, a decline of 100% from the average session volume of 14,401 shares. The stock had previously closed at GBX 76 ($0.96).
Arecor Therapeutics Trading Up 2.6 %
The stock’s 50-day simple moving average is GBX 72.25 and its two-hundred day simple moving average is GBX 100.01. The firm has a market capitalization of £29.45 million, a P/E ratio of -278.57 and a beta of -0.18. The company has a debt-to-equity ratio of 5.51, a current ratio of 1.37 and a quick ratio of 6.24.
About Arecor Therapeutics
Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.
Further Reading
- Five stocks we like better than Arecor Therapeutics
- Are Penny Stocks a Good Fit for Your Portfolio?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Calculate Stock Profit
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is a support level?
- Time to Load Up on Home Builders?
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
